Official 2024 U.S. DOL Form 5500 summary for Taysha Gene Therapies, INC. (Taysha Gene Therapies 401(k) Plan · EIN 84-3199512 · PN 001): $6.17M net assets, 73 active participants, and Sponsor-paid or unbenchmarked.
| Plan Sponsor | Taysha Gene Therapies, INC. |
|---|---|
| Filing Identifier | Taysha Gene Therapies 401(k) Plan · EIN 84-3199512 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (TX) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $6.17M |
| Active Participants | 73 |
| Direct Admin Fee Rate | Sponsor-paid or unbenchmarked |
| Cohort Peer Median | N/A |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI